Return On Equity of Outlook Therapeutics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Outlook Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Outlook Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 164%, a 72% increase year-over-year.
  • Outlook Therapeutics, Inc. annual Return On Equity for 2025 was 164%, a 72% increase from 2024.
  • Outlook Therapeutics, Inc. annual Return On Equity for 2024 was 96%.
  • Outlook Therapeutics, Inc. annual Return On Equity for 2023 was -3742%, a 1509% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Outlook Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 164% +69% +72% 01 Jul 2025 30 Sep 2025
Q2 2025 90% -57% -39% 01 Apr 2025 30 Jun 2025
Q1 2025 -35% -392% -110% 01 Jan 2025 31 Mar 2025
Q4 2024 55% -555% -91% 01 Oct 2024 31 Dec 2024
Q3 2024 96% +3837% 01 Jul 2024 30 Sep 2024
Q2 2024 147% +965% 01 Apr 2024 30 Jun 2024
Q1 2024 357% +772% 01 Jan 2024 31 Mar 2024
Q4 2023 610% +958% 01 Oct 2023 31 Dec 2023
Q3 2023 -3742% -3509% -1509% 01 Jul 2023 30 Sep 2023
Q2 2023 -819% -581% -244% 01 Apr 2023 30 Jun 2023
Q1 2023 -416% -181% -78% 01 Jan 2023 31 Mar 2023
Q4 2022 -349% -104% -42% 01 Oct 2022 31 Dec 2022
Q3 2022 -233% +540% +70% 01 Jul 2022 30 Sep 2022
Q2 2022 -238% +534% +69% 01 Apr 2022 30 Jun 2022
Q1 2022 -234% +442% +65% 01 Jan 2022 31 Mar 2022
Q4 2021 -245% -1014% -132% 01 Oct 2021 31 Dec 2021
Q3 2021 -772% -1147% -306% 01 Jul 2021 30 Sep 2021
Q2 2021 -772% -1022% -408% 01 Apr 2021 30 Jun 2021
Q1 2021 -676% -875% -440% 01 Jan 2021 31 Mar 2021
Q4 2020 769% +567% +280% 01 Oct 2020 31 Dec 2020
Q3 2020 374% +195% +109% 01 Jul 2020 30 Sep 2020
Q2 2020 250% +81% +48% 01 Apr 2020 30 Jun 2020
Q1 2020 199% +24% +14% 01 Jan 2020 31 Mar 2020
Q4 2019 203% +49% +32% 01 Oct 2019 31 Dec 2019
Q3 2019 179% +55% +45% 01 Jul 2019 30 Sep 2019
Q2 2019 169% +77% +84% 01 Apr 2019 30 Jun 2019
Q1 2019 174% +105% +150% 01 Jan 2019 31 Mar 2019
Q4 2018 154% +78% +103% 01 Oct 2018 31 Dec 2018
Q3 2018 124% -16% -12% 01 Jul 2018 30 Sep 2018
Q2 2018 92% -116% -56% 01 Apr 2018 30 Jun 2018
Q1 2018 70% -389% -85% 01 Jan 2018 31 Mar 2018
Q4 2017 76% -275% -78% 01 Oct 2017 31 Dec 2017
Q3 2017 140% 01 Jul 2017 30 Sep 2017
Q2 2017 208% 01 Apr 2017 30 Jun 2017
Q1 2017 459% 01 Jan 2017 31 Mar 2017
Q4 2016 351% 01 Oct 2016 31 Dec 2016

Outlook Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 164% +69% +72% 01 Oct 2024 30 Sep 2025
2024 96% +3837% 01 Oct 2023 30 Sep 2024
2023 -3742% -3509% -1509% 01 Oct 2022 30 Sep 2023
2022 -233% +540% +70% 01 Oct 2021 30 Sep 2022
2021 -772% -1147% -306% 01 Oct 2020 30 Sep 2021
2020 374% +195% +109% 01 Oct 2019 30 Sep 2020
2019 179% +55% +45% 01 Oct 2018 30 Sep 2019
2018 124% -16% -12% 01 Oct 2017 30 Sep 2018
2017 140% 01 Oct 2016 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.